MEDIFAST INC — Director's Dealing 2023

May 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-02-24

Reporting Person: Chard Daniel R (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-24	Common Stock	A	34076	—	Acquired	48194	Direct
2023-02-24	Common Stock	F	15643	$109.99	Disposed	32551	Direct
2023-03-16	Common Stock	F	1358	$104.46	Disposed	31193	Direct
2023-03-17	Common Stock	F	872	$102.75	Disposed	30321	Direct
2023-03-17	Common Stock	A	16807	—	Acquired	47128	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	108598.352	Indirect

Footnotes

F1: 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023.

F2: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.